Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 633

1.

Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.

Lamberti JS, Costea GO, Olson D, Crilly JF, Maharaj K, Tu X, Groman A, Dietz MB, Bushey MP, Olivares T, Wiener K.

J Clin Psychiatry. 2005 Jul;66(7):900-6.

PMID:
16013906
2.

Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs.

Lamberti JS, Crilly JF, Maharaj K, Olson D, Wiener K, Dvorin S, Costea GO, Bushey MP, Dietz MB.

J Clin Psychiatry. 2004 May;65(5):702-6.

PMID:
15163259
3.

Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.

Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC.

J Clin Psychiatry. 2005 Sep;66(9):1116-21.

PMID:
16187768
4.

Prevalence of the metabolic syndrome among patients receiving clozapine.

Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, Tang W, Wiener K, Dvorin S, Dietz MB.

Am J Psychiatry. 2006 Jul;163(7):1273-6.

PMID:
16816234
5.

Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.

Nihalani ND, Tu X, Lamberti JS, Olson D, Olivares T, Costea GO, Tang W.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):105-12. Review. Erratum in: Ann Clin Psychiatry. 2007 Oct-Dec;19(4):329. Tu, Xin [added].

PMID:
17612850
6.

Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.

Sernyak MJ, Gulanski B, Leslie DL, Rosenheck R.

J Clin Psychiatry. 2003 May;64(5):605-8.

PMID:
12755666
7.
8.

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

Wheeler AJ.

Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.

PMID:
18477732
9.

The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.

Zhang R, Hao W, Pan M, Wang C, Zhang X, Chen DC, Xiu MH, Yang FD, Kosten TR, Zhang XY.

Hum Psychopharmacol. 2011 Aug;26(6):392-6. doi: 10.1002/hup.1220. Epub 2011 Aug 8.

PMID:
21826737
10.

The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.

Miodownik C, Lerner V, Kibari A, Toder D, Cohen H.

J Clin Psychiatry. 2006 Aug;67(8):1204-8.

PMID:
16965197
11.
12.

Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.

Cohen D, Dekker JJ, Peen J, Gispen-de Wied CC.

Eur Neuropsychopharmacol. 2006 Apr;16(3):187-94. Epub 2005 Nov 2.

PMID:
16263247
13.

Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.

Sernyak MJ, Gulanski B, Rosenheck R.

J Clin Psychiatry. 2005 Nov;66(11):1463-7.

PMID:
16420085
14.

Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.

Miller MJ, Molla PM.

Arch Psychiatr Nurs. 2005 Feb;19(1):30-4.

PMID:
15765369
15.

Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.

Schneiderhan ME, Batscha CL, Rosen C.

Pharmacotherapy. 2009 Aug;29(8):975-87. doi: 10.1592/phco.29.8.975.

PMID:
19637951
16.

Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.

Brunero S, Lamont S, Fairbrother G.

Arch Psychiatr Nurs. 2009 Jun;23(3):261-8. doi: 10.1016/j.apnu.2008.06.007. Epub 2009 Jan 15.

PMID:
19446781
17.

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC.

J Clin Psychiatry. 2004 Oct;65(10):1372-6.

PMID:
15491241
18.

Clozapine and hypertension: a chart review of 82 patients.

Henderson DC, Daley TB, Kunkel L, Rodrigues-Scott M, Koul P, Hayden D.

J Clin Psychiatry. 2004 May;65(5):686-9.

PMID:
15163256
19.

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

Cohen D, Stolk RP, Grobbee DE, Gispen-de Wied CC.

Diabetes Care. 2006 Apr;29(4):786-91.

PMID:
16567816
20.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

Supplemental Content

Support Center